Moderna Inc (MRNA) is a drug discovery and vaccine development company based out of Cambridge, Massachusetts. The company went public in 2018 and became the biggest Biotech IPO to date.
The MRNA IPO raised approximately $621 million and went live on Nasdaq trading at $18.60. Since then, the company has been at the forefront of vaccine development for several diseases including COVID.
Moderna's financials have been in the red since the start but the company outperformed its Q4 2020 expectations. Moreover, MRNA is currently* trading at nearly 6x its value since being listed on NASDAQ.
In this story, we'll take a look at the current numbers of Moderna Inc and the MRNA stock to understand the present and future financial health of the company.
Important: Please consult a wealth coach or financial advisor before investing in any US stock.
on stock picking, poring over excel sheets, financial news, analyzing market trends, tracking the Sensex, researching company fundamentals, comparing mutual funds, reading financial reports, trying to predict the future & losing your sanity!